LINC00665的上调与侵袭性肝细胞癌和不良预后相关
Qiangqiang Zhong1, Baokang Zhao2, Yunhua Zhou3
1Department of Gastroenterology, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Combinatorial chemistry & high throughput screening
|March 14, 2026
概括
长非编码RNA LINC00665在肝细胞癌 (HCC) 中被上调,导致扩散和转移. LINC00665显示出作为HCC的预后生物标志物和治疗点的潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 基因组学就是基因组学.
背景情况:
- 长非编码RNA LINC00665与癌细胞增殖和转移有关.
- 在肝细胞癌 (HCC) 诊断和预后中LINC00665的作用尚未得到充分研究.
研究的目的:
- 研究LINC00665在HCC中的作用.
- 评估LINC00665作为HCC的诊断和预后生物标志物.
- 探索LINC00665与瘤微环境和瘤性途径的关联.
主要方法:
- 在TCGA和GTEx数据集中分析LINC00665表达式.
- 与临床病理学特征,生存率和考克斯回归相关性分析.
- 基因组丰富分析 (GSEA) 用于途径调查.
- 免疫细胞透分析和体外功能测定.
主要成果:
- 在HCC组织中,LINC00665的活性显著升高.
- 升高的LINC00665表达与不良的临床病理特征和不良预后相关.
- LINC00665与免疫抑制性瘤微环境和瘤性途径有关.
- 沉默LINC00665抑制HCC细胞的增殖和入侵.
结论:
- 在HCC中,LINC00665作为致癌驱动因素和预后生物标志物.
- LINC00665与瘤进展,转移和免疫抑制微环境有关.
- 针对LINC00665在HCC中的治疗策略需要进一步验证.
相关概念视频
02:39lncRNA - Long Non-coding RNAs
10.1K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.1K
02:23Abnormal Proliferation
5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K